GlassScriptPhysician profile
Richard A Noto
NPI 1891795647
$3,501.83
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,673 · 2020: $454 · 2021: $1,212 · 2022: $163.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,466.19 | 2019-2022 | |
| Abbvie INC. | $464.15 | 2019-2022 | |
| Sandoz INC. | $179.62 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $172.84 | 2019 | |
| Medtronic Minimed, INC. | $130.26 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $116.98 | 2019-2021 | |
| Lilly USA, LLC | $116.97 | 2019-2020 | |
| Insulet Corporation | $89.18 | 2019 | |
| Medtronic, INC. | $85.60 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $85.42 | 2020-2022 | |
| Ferring Pharmaceuticals INC. | $81.34 | 2019-2020 | |
| Dexcom, INC. | $80.43 | 2019-2020 | |
| Mannkind Corporation | $78.49 | 2019-2020 | |
| Becton, Dickinson and Company | $71.09 | 2019 | |
| Pfizer INC. | $66.06 | 2019-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $51.94 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $47.72 | 2019 | |
| Ibsa Pharma INC. | $40.57 | 2019 | |
| Tandem Diabetes Care, INC. | $40.09 | 2019-2020 | |
| Companion Medical, INC. | $20.52 | 2020 | |
| Ascendis Pharma Endocrinology INC | $16.37 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Noto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.